Lv2
200 积分 2023-05-23 加入
Trends in the development of cellular and gene therapy in China
9个月前
已完结
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study
9个月前
已完结
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy
9个月前
已完结
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
10个月前
已完结
2024 FDA approvals
10个月前
已完结
皖公网安备34019202002308
